Global Smart Diabetes Management Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns& country along with competitive landscape, player’s market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions.
Smart Diabetes Management Market Definition and Brief Overview:
Diabetes is a chronic disease, and its treatment requires intensive management of medication, diet, and exercise. Information and communication technology provides diverse facilities to patients and medical specialists to manage different diseases in an efficient manner with the help of smartphone technology. Diabetes is a metabolic disorder that occurs due to defects in insulin secretion, insulin action, or genetic issues. The mHealth platforms include mobile phones, tablets, and in-built body sensors that transmit disease-related vital signs data such as blood pressure and pulse rate.
Major Players in This Report Include,
Dexcom, Inc. (United States), Smart Meter LLC (United States), Insulet Corporation (United States), LifeScan, Inc. (United States), Abbott…
